Article Versions Notes

Tomita Y, Smith E, Palethorpe HM, Nakhjavani M, Yeo KKL, Townsend AR, Price TJ, Yool AJ, Hardingham JE. In Vitro Synergistic Inhibition of HT-29 Proliferation and 2H-11 and HUVEC Tubulogenesis by Bacopaside I and II Is Associated with Ca²⁺ Flux and Loss of Plasma Membrane Integrity. Pharmaceuticals. 2021; 14(5):436. https://doi.org/10.3390/ph14050436

Tomita, Yoko, Eric Smith, Helen M. Palethorpe, Maryam Nakhjavani, Kenny K. L. Yeo, Amanda R. Townsend, Timothy J. Price, Andrea J. Yool, and Jennifer E. Hardingham. 2021. "In Vitro Synergistic Inhibition of HT-29 Proliferation and 2H-11 and HUVEC Tubulogenesis by Bacopaside I and II Is Associated with Ca²⁺ Flux and Loss of Plasma Membrane Integrity" Pharmaceuticals 14, no. 5: 436. https://doi.org/10.3390/ph14050436

Tomita, Y., Smith, E., Palethorpe, H. M., Nakhjavani, M., Yeo, K. K. L., Townsend, A. R., Price, T. J., Yool, A. J., & Hardingham, J. E. (2021). In Vitro Synergistic Inhibition of HT-29 Proliferation and 2H-11 and HUVEC Tubulogenesis by Bacopaside I and II Is Associated with Ca²⁺ Flux and Loss of Plasma Membrane Integrity. Pharmaceuticals, 14(5), 436. https://doi.org/10.3390/ph14050436